Private equity firms buys specialty pharma company WellSpring
This article was originally published in Scrip
Executive Summary
A private equity consortium has bought WellSpring Pharmaceutical, a North American manufacturer and marketer of specialty prescription and OTC products, and its Canadian contract manufacturing plant.